These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28371620)

  • 21. Neonatal abstinence syndrome.
    Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE
    Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.
    Noormohammadi A; Forinash A; Yancey A; Crannage E; Campbell K; Shyken J
    Ann Pharmacother; 2016 Aug; 50(8):666-72. PubMed ID: 27199497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone maintenance and breastfeeding in the neonatal period.
    Liu AJ; Nanan R
    Pediatrics; 2008 Apr; 121(4):869; author reply 869-70. PubMed ID: 18381558
    [No Abstract]   [Full Text] [Related]  

  • 24. Systematic Review of Newborn Feeding Method and Outcomes Related to Neonatal Abstinence Syndrome.
    McQueen K; Taylor C; Murphy-Oikonen J
    J Obstet Gynecol Neonatal Nurs; 2019 Jul; 48(4):398-407. PubMed ID: 31034790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal buprenorphine treatment and infant outcome.
    Jansson LM; Velez ML; McConnell K; Spencer N; Tuten M; Jones H; Rios R; King VL; Gandotra N; Millio L; DiPietro JA
    Drug Alcohol Depend; 2017 Nov; 180():56-61. PubMed ID: 28869859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.
    Bandstra ES
    Addiction; 2012 Nov; 107 Suppl 1():1-4. PubMed ID: 23106922
    [No Abstract]   [Full Text] [Related]  

  • 27. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome.
    Isemann B; Meinzen-Derr J; Akinbi H
    J Perinatol; 2011 Jan; 31(1):25-9. PubMed ID: 20508596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Maternal lactation in mothers undergoing treatment with methadone substitution].
    Lemire L
    Soins Pediatr Pueric; 2006; (231):27-9. PubMed ID: 17017645
    [No Abstract]   [Full Text] [Related]  

  • 30. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S; Martin PR
    Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breastfeeding in Women on Opioid Maintenance Therapy: A Review of Policy and Practice.
    Clark RRS
    J Midwifery Womens Health; 2019 Sep; 64(5):545-558. PubMed ID: 31294522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of a Prenatal Education Program for Opioid-Dependent Mothers on Breastfeeding Rates of Infants at Risk for Neonatal Abstinence Syndrome.
    Brocato B; Lewis D; Eyal F; Baker S; Armistead C; Kaye AD; Cornett EM; Whitehurst RM
    Adv Ther; 2022 Jul; 39(7):3104-3111. PubMed ID: 35522394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of Maternal-Infant Interaction During Treatment for Opioid Withdrawal.
    Maguire DJ; Taylor S; Armstrong K; Shaffer-Hudkins E; DeBate R; Germain AM; Brooks SS
    Neonatal Netw; 2016; 35(5):297-304. PubMed ID: 27636694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy.
    ;
    Obstet Gynecol; 2012 May; 119(5):1070-6. PubMed ID: 22525931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of neonatal abstinence syndrome in the newborn nursery.
    Artigas V
    Nurs Womens Health; 2014 Dec; 18(6):509-14. PubMed ID: 25495971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K; Morrone WR; O'Grady KE; Jones HE
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supporting breastfeeding for women on opioid maintenance therapy: a systematic review.
    Doerzbacher M; Chang YP
    J Perinatol; 2019 Sep; 39(9):1159-1164. PubMed ID: 31263203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.
    Mactier H; McLaughlin P; Gillis C; Osselton MD
    Am J Perinatol; 2017 Jul; 34(9):918-921. PubMed ID: 28320034
    [No Abstract]   [Full Text] [Related]  

  • 39. [Breast feeding during methadon- and buprenorphin therapy].
    Müller MJ; Lange M; Paul T; Seeliger S
    Klin Padiatr; 2011 Dec; 223(7):408-13. PubMed ID: 21969026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mothers on methadone: care in the NICU.
    Maguire DJ
    Neonatal Netw; 2013; 32(6):409-15. PubMed ID: 24195801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.